Eli Lilly says it will file for approval of next-generation obesity drug in 2027 as it clears two more trials
Eli Lilly on Thursday said it will file for approval of its next-generation obesity drug in the first quarter of...
Tema
Eli Lilly
STAT+: New data on Eli Lilly’s ‘triple-G’ drug leave open questions on heart benefit
Eli Lilly reported more results Thursday showing that its next-generation obesity drug is highly efficacious at...
Ozempic-maker accuses rival of false advertising
Ozempic-maker accuses rival of false advertising - Published The maker of Wegovy and Ozempic, Novo Nordisk, has...
STAT+: Novo Nordisk sues Eli Lilly over GLP-1 drug ads it calls ‘deceptive’
Novo Nordisk on Tuesday sued Eli Lilly for allegedly running a “deceptive” ad campaign that uses...
Novo Nordisk sues Eli Lilly, alleging misleading GLP-1 advertising
Novo Nordisk on Tuesday filed a lawsuit against Eli Lilly, alleging that its advertising campaigns for its...
Eli Lilly e Regeneron são selecionadas para programa da FDA que acelera revisão de fábricas farmacêuticas
A FDA dos EUA lançou um programa piloto para acelerar a revisão de novas instalações farmacêuticas, com Eli Lilly e...
Democratas questionam acesso especial ao medicamento contra obesidade de Eli Lilly
Através de um programa de uso compasivo, a empresa farmacêutica Eli Lilly e a FDA ofereceram ao paciente o...
Caso intrigante do medicamento para obesidade da Eli Lilly
Um paciente teve acesso ao retatrutide, medicamento para obesidade da Eli Lilly, através do programa de uso...
Página 1